Friday, January 16, 2026 2:12:11 PM
O Lord of the Market,
guardian of charts and ruler of spreads,
you who move volumes and decide fates
with a careless click or a moody algorithm,
sometimes aligned in mysterious sevens,
cast your eye—if you must—upon HCWB.
We ask not for meme-stock miracles,
nor green candles worthy of the Apocalypse.
Just a measure of mercy,
a future not built solely
on reverse splits and ritual dilution.
A sign would suffice—
even a modest 7, not a jackpot, just a hint.
If among its molecules
there is at least one truly worth living,
not merely a promise on a slide
but substance, mechanism, clinical rationale,
let it surface.
Illuminate the data—
three clean signals, not three excuses.
And if there is nothing good at all,
if everything is just well-packaged storytelling,
grant us the wisdom to see it in time
and the courage to press “sell”
without regret,
before the next filing resets the count back to zero.
Protect us from thin markets,
from overenthusiastic PR,
from dilution dressed as destiny,
and from shorts with 777-level divine timing.
Amen…. Just to say.
guardian of charts and ruler of spreads,
you who move volumes and decide fates
with a careless click or a moody algorithm,
sometimes aligned in mysterious sevens,
cast your eye—if you must—upon HCWB.
We ask not for meme-stock miracles,
nor green candles worthy of the Apocalypse.
Just a measure of mercy,
a future not built solely
on reverse splits and ritual dilution.
A sign would suffice—
even a modest 7, not a jackpot, just a hint.
If among its molecules
there is at least one truly worth living,
not merely a promise on a slide
but substance, mechanism, clinical rationale,
let it surface.
Illuminate the data—
three clean signals, not three excuses.
And if there is nothing good at all,
if everything is just well-packaged storytelling,
grant us the wisdom to see it in time
and the courage to press “sell”
without regret,
before the next filing resets the count back to zero.
Protect us from thin markets,
from overenthusiastic PR,
from dilution dressed as destiny,
and from shorts with 777-level divine timing.
Amen…. Just to say.
Recent HCWB News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/17/2026 09:23:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 09:12:29 PM
- HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results • GlobeNewswire Inc. • 03/31/2026 09:05:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 12:00:07 PM
- HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic • GlobeNewswire Inc. • 03/17/2026 11:50:00 AM
- HCW Biologics highlights positive findings for CAR-T therapy manufacturing • IH Market News • 03/16/2026 02:31:28 PM
- HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances • GlobeNewswire Inc. • 03/16/2026 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/13/2026 08:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 01:08:36 PM
- HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:43:57 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/19/2026 08:46:38 PM
- HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules • GlobeNewswire Inc. • 02/18/2026 02:50:56 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/17/2026 02:09:25 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/13/2026 09:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 01:38:42 PM
- HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune • GlobeNewswire Inc. • 02/13/2026 01:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/11/2026 10:27:05 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/30/2026 05:15:19 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/09/2026 09:49:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/31/2025 05:36:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:30:26 PM
- HCW Biologics Enters into $4.0 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 11/19/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 12:30:26 PM
